The core activity of Breslin AG is the provision of corporate finance services, including: capital raising, mergers & acquisitions, buyouts, initial public offerings, financial structuring, corporate development, spin-offs, advisory and transaction support. The company specializes in the life sciences and pharmaceutical industry and provides strategic advisory and transaction support to companies in this sector.
AI-generated
Offering
Products & services
Industry:Financial Services
✓ Offered
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Secondary portfolio sales, LP- and GP-led processes, and externalisation of non-strategic business assets; preparation, market testing, execution and closing.
Corporate Finance and Fundraising
Private placements, growth financing, follow-on financings, structured equity and hybrid capital solutions, as well as debentures, convertibles, loan and debt solutions.
Strategic Transactions and M&A Advisory
Sell-side and buy-side mandates, divestments, carve-outs, strategic reviews and non-core asset disposals with valuation framing, diligence support and deal negotiation coordination.
Partnering, Licensing and Spin-offs
Strategic partnerships, out- and in-licensing, partner search, commercial alliances, cross-border market access, and the launch of academic and industrial spin-offs.
Private Market Investments
Investments in seed- to early-stage ventures, as well as academic and industrial spin-offs, with capital, strategic support and participation across multiple development phases.
Knowledge
No knowledge articles yet
Once Breslin AG has claimed this profile, we'll publish editorial articles and case studies here together.